Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 161 to 170 of 191 resources

  • Guidance on testing for hepatitis B and C (with reference to HIV) Developed by Yorkshire and the Humber Hepatitis B and C Steering Group
    Individuals with chronic hepatitis (B and C) can be treated, which reduces the likelihood of chronic illness and premature death. Recognition of infection and treatment may also reduce the spread of infection. In 2010 across Yorkshire and the Humber there were 427 cases of hepatitis B (of which 39 were acute) and 980 newly identified hepatitis C infections reported through NHS/HPA laboratory testing, however HPA estimates calculate that there are over 20,000 people actually infected with hepatitis C in the region.
    Yorkshire and the Humber Mar 2012 Tools & Templates, Strategy & Planning PDF
  • Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
    This paper reports on the results of a 2011 EASL meeting and subsequent dialogue with patient groups and relevant experts in Europe. It summarises the current knowledge of HCV infection and the brain; prevalence, course, and neurobiology of IFN-a associated psychiatric side effects; possible risk factors for IFN-a associated depression and suicide attempts; psychiatric management of HCV infected patients before and during antiviral treatment; prevention of IFN- a associated psychiatric side effects; and psychiatric aspects of the new antivirals.
    UK, Rest of World 2012 Reports & Research PDF
  • The Silent Pandemic: Tackling Hepatitis C with Policy Innovation
    Hepatitis C may be the serious disease that most combines widespread prevalence with widespread ignorance. According to the World Health Organisation (WHO), this urgent public health problem kills 350,000 people per year, and 150 million have the chronic form of the hepatitis C virus (HCV). The incidence of new infections is simply not known at the global level. Yet, HCV is entirely preventable and largely curable.
    UK, Rest of World 2012 Reports & Research PDF
  • Yorkshire and the Humber Quality Standards Framework for Hepatitis B and C: 2012
    In order to address the prevention and burden of hepatitis C (and B) effectively it is important that the four key elements of the pathway are in place as defined by the Department of Health. Whilst there have been many developments since 2004, this Quality Standards Framework still focuses on the four key elements of the hepatitis B and C pathway but provides more detail on how, in Yorkshire and the Humber, stakeholders can work effectively to deliver a quality pathway to patients regarding hepatitis B and C.
    Yorkshire and the Humber 2012 Other, Reports & Research PDF
  • The Hepatitis C Trust Outreach & Testing Van
    This document summarises The Hepatitis C Trust’s Outreach and Testing Van service, which aims to increase diagnoses by reaching groups who may be at risk of hep C but who currently cannot, or do not, access testing through existing means. Given that most people in the UK today are undiagnosed, the testing van aims to overcome some of the key barriers to diagnosis.
    England 2011 Case study, Reports & Research PDF
  • Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
    The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.
    North West 2011 Case study, Strategy & Planning PDF
  • The Sexual Health and Blood Borne Virus Framework 2011-15
    Sexual health and blood borne viruses continue to be of high priority for the Scottish Government. The Sexual
    Scotland Aug 2011 Reports & Research PDF
  • Hepatitis C - Treatment and follow-up
    Valid until May 2014, this document provides a map of medicine for the treatment and follow-up of Hepatitis C.
    England 06 Jun 2011 Training, Tools & Templates PDF
  • Government response to the NHS Future Forum report
    Between April and June 2011, the NHS Future Forum, led by Professor Steve Field, heard the views of thousands of people – patients, professionals and members of the public. They listened to every professional group and toured every region in the country, producing a report for the Government on 13th June. The NHS Future Forum confirmed that there was considerable support for the principles of the Government’s reforms, but said that some of the ways in which it was putting those principles into practice could be improved.
    England Jun 2011 Reports & Research PDF
  • Hepatitis C - secondary care assessment
    Valid until May 2014, this document provides a map of medicine for secondary care assessment of Hepatitis C.
    England 29 Apr 2011 Tools & Templates PDF

Pages